Global pharmaceutical outsourcing offers companies an opportunity to face these challenges. By forming strategic relationships with outsourcing partners, companies can focus on core competencies, access specialised expertise, achieve cost-saving benefits and reduce burn rates that lead directly to greater shareholder value.
Over the past two decades, the outsourcing of R&D and manufacturing processes has become increasingly prevalent, and is now a major trend in the pharmaceutical industry. Pharmaceutical companies have moved up the value chain for outsourcing from non-core functions, such as IT and human resources, to secondary core functions. Key drivers behind the trend include:
PwC provides solid, independent insights into identifying, selecting and working with global outsourcing and off-shoring partners.